In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Oncology Institute Inc (NASDAQ: TOI) was $0.31 for the day, down -3.44% from the previous closing price of $0.32. In other words, the price has decreased by -$3.44 from its previous closing price. On the day, 1.05 million shares were traded. TOI stock price reached its highest trading level at $0.348 during the session, while it also had its lowest trading level at $0.2834.
Ratios:
Our analysis of TOI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.27 and its Current Ratio is at 2.49. In the meantime, Its Debt-to-Equity ratio is 7.94 whereas as Long-Term Debt/Eq ratio is at 7.51.
On September 14, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $7.
On August 15, 2022, Jefferies started tracking the stock assigning a Buy rating and target price of $10.Jefferies initiated its Buy rating on August 15, 2022, with a $10 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 26 ’24 when Hively Brad bought 250,000 shares for $0.17 per share. The transaction valued at 42,500 led to the insider holds 616,753 shares of the business.
Hively Brad bought 50,000 shares of TOI for $7,500 on Dec 02 ’24. The Director now owns 666,753 shares after completing the transaction at $0.15 per share. On Jan 29 ’24, another insider, Havencrest Healthcare Partners, who serves as the 10% Owner of the company, sold 8,637 shares for $2.12 each. As a result, the insider received 18,310 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOI now has a Market Capitalization of 23347762 and an Enterprise Value of 92398360. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.06 while its Price-to-Book (P/B) ratio in mrq is 1.51. Its current Enterprise Value per Revenue stands at 0.256 whereas that against EBITDA is -1.611.
Stock Price History:
Over the past 52 weeks, TOI has reached a high of $2.50, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is 28.30%, while the 200-Day Moving Average is calculated to be -44.21%.
Shares Statistics:
TOI traded an average of 1.75M shares per day over the past three months and 959910 shares per day over the past ten days. A total of 75.56M shares are outstanding, with a floating share count of 36.80M. Insiders hold about 51.29% of the company’s shares, while institutions hold 16.30% stake in the company. Shares short for TOI as of 1730332800 were 247975 with a Short Ratio of 0.10, compared to 1727654400 on 252527. Therefore, it implies a Short% of Shares Outstanding of 247975 and a Short% of Float of 0.5.
